Stevens-Johnson Syndrome in patients receiving cranial irradiation and concomitant diphenylhydantoin

Turkish Journal of Cancer

Volumn 32, Issue 4, 2002, Pages 164-171

  Topkan, Erkan ^a   Zorlu, Faruk ^a   Gürkaynak, Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Brain metastasis; Cranial irradiation; Diphenylhydantoin; Stevens Johnson Syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CORTICOSTEROID; DEXAMETHASONE; FAMOTIDINE; PHENYTOIN; PREDNISOLONE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CANCER; BRAIN METASTASIS; BRAIN RADIATION; BRAIN SURGERY; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; HUMAN; LUNG CARCINOMA; MALE; METASTASIS; POSTOPERATIVE CARE; SEIZURE; STEVENS JOHNSON SYNDROME;

EID: 0042859820     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chan HL, Stern RS, Kenneth AA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43-7.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
3. Atahan IL, Ozyar E, Sahin S, et al. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy. Br J Dermatol 2000;143:1072-3.
4. Bianchine JR, Macrareg PVJ, Lasagna L, et al. Drugs as etiologic factors in the Stevens-Johnson syndrome. Am J Med 1968;44:390-403
5. Borg MF, Probert JC, Zwi LJ. Is phenytoin contraindicated in patients receiving cranial irradiation? Australas Radiol 1995;39:42-6.
6. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson Syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
7. Marvin JA, Heimbach DM, Engrav LH, et al. Improved treatment of Stevens-Johnson syndrome. Arch Surg 1984;119:601-5.
8. Hyman LR, Ballow M, Knieser MR. Diphenylhydantoin interstitial nephritis: roles of cellular and humoral immunological injuries. J Pediatr 1978;92:915-20.
9. Harney J, Glasberg MR. Myopathy and hypersensitivity to phenytoin. Neurology 1983;33:790-1.
10. Wolkenstein P, Charue D, Laurent P, et al. Metabolic predisposition of cutaneous adverse drug reactions, role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995;131:544-51.
11. Halvey S, Grunwald MH, Sandbank M, et al. Macrophage migration inhibition factor (MIF) in drug eruption. Arch Dermatol 1990;126:48-51.
12. Guibal F, Bastuji-Garin S, Chosidow O, et al. Characteristics of toxic epidermal necrolysis in patients undergoing long term glucocorticoid therapy. Arch Dermatol 1995;131:669-72.
13. Gleichman H. Studies on mechanism of drug sensitization: T-cell dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunpathol 1981;18:203-11.
14. Roujeau JC, Hynth TN, Bracq C, et al. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987;123:1171-3.
15. Dellatre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988;38:194-8.
16. Maiche A, Teerenhovi L. Stevens-Johnson syndrome in patients receiving radiation therapy. Lancet 1985;2:45.
17. Fitzpatrick TB, Bernhard JD. Skin lesions of general medical significance. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, editors. Harrison's principles of internal medicine. 11th edition. New York: Mc Graw Hill Book Co., 1987;232-40.
18. Guibal F, Bastuji-Garin S, Chosidow O, et al. Characteristics of toxic epidermal necrolysis in patients undergoing long term glucocorticoid therapy. Arch Dermatol 1995;131:669-72.
19. Mamon HJ, Wen PY, Burns AC, et al. Allergic skin reactions to anticonvulsant medications in patients receiving cranial irradiation. Epilepsia 1999;40:341-4.